CHADS2 scores in the prediction of major adverse cardiovascular events in patients with cushing's syndrome

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Wang, Yuh Feng ^a,b   Chuang, Mei Hua ^c   Chuang, Tzyy Ling ^a   Huang, Kung Yung ^b,c   Lyu, Shaw Ruey ^a,b   Huang, Chih Yuan ^b,c   Lee, Ching Chih ^a,b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c Buddist Tzu Chi College of Nursing   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHADS2 SCORE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CUSHING SYNDROME; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN;

EID: 84904610022     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/138653     Document Type: Article

References (24)

1. Castinetti F., Morange I., Conte-Devolx B., Brue T., Cushings disease. Orphanet Journal of Rare Diseases 2012 7 1, article 41 10.1186/1750-1172-7-41 2-s2.0-84866742520
2. Obiols Alfonso G., Biagetti Biagetti B., Chacon Oreja A., Salvador Rodriguez J., Cushing's disease in 2012. Endocrinología y Nutrición 2014 61 2 93 99
3. Bertagna X., Guignat L., Groussin L., Bertherat J., Cushing's disease. Best Practice and Research: Clinical Endocrinology and Metabolism 2009 23 5 607 623 10.1016/j.beem.2009.06.001 2-s2.0-71749092034
4. Nieman L. K., Biller B. M., Findling J. W., The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 2008 93 5 1526 1540 10.1210/jc.2008-0125 (Pubitemid 351656485)
5. Minetto M., Reimondo G., Osella G., Ventura M., Angeli A., Terzolo M., Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporosis International 2004 15 11 855 861 10.1007/s00198-004-1616-3 2-s2.0-8644286156 (Pubitemid 39506451)
6. Mancini T., Kola B., Mantero F., Boscaro M., Arnaldi G., High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clinical Endocrinology 2004 61 6 768 777 10.1111/j.1365-2265.2004.02168.x 2-s2.0-10844237159 (Pubitemid 40006799)
7. di Dalmazi G., Vicennati V., Garelli S., Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. The Lancet Diabetes & Endocrinology 2014
8. Dekkers O. M., Horváth-Puhó E., Jørgensen J. O., Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. The Journal of Clinical Endocrinology & Metabolism 2013 98 6 2277 2284 10.1210/jc.2012-3582
9. Steffensen C., Bak A. M., Zøylner Rubeck K., Jørgensen J. O. L., Epidemiology of Cushing's syndrome. Neuroendocrinology 2010 92 1 1 5 10.1159/000314297 2-s2.0-77956512217
10. Baruch L., Gage B. F., Horrow J., Juul-Möller S., Labovitz A., Persson M., Zabalgoitia M., Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? Stroke 2007 38 9 2459 2463 10.1161/STROKEAHA.106.477133 2-s2.0-34548274066 (Pubitemid 47329622)
11. Hylek E. M., Evans-Molina C., Shea C., Henault L. E., Regan S., Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007 115 21 2689 2696 10.1161/CIRCULATIONAHA.106.653048 2-s2.0-34249715284 (Pubitemid 46842784)
12. 2 score. Thrombosis Research 2007 121 3 347 352 10.1016/j.thromres.2007.05.014 2-s2.0-34948856297
13. Fuster V., Ryden L. E., Cannom D. S., ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Journal of the American College of Cardiology 2006 48 4 854 906 10.1016/j.jacc.2006.07.009 (Pubitemid 44175743)
14. Gage B. F., Waterman A. D., Shannon W., Boechler M., Rich M. W., Radford M. J., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. The Journal of the American Medical Association 2001 285 22 2864 2870 10.1001/jama.285.22.2864 2-s2.0-0035854054 (Pubitemid 32537350)
15. 2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. Chest 2011 139 6 1402 1409 10.1378/chest.10-1408 2-s2.0-79958741381
16. Ruwald M. H., Ruwald A., Jons C., Lamberts M., Hansen M. L., Vinther M., Køber L., Torp-Pedersen C., Hansen J., Gislason G. H., Evaluation of the chads2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope. Clinical Cardiology 2013 36 5 262 268 10.1002/clc.22102 2-s2.0-84877763117
17. 2VASc stroke risk stratification schemes. The Journal of Thoracic and Cardiovascular Surgery 2012 144 6 1428 1435 10.1016/j.jtcvs. 2012.07.053 2-s2.0-84869087514
18. Stöllberger C., Wegner C., Finsterer J., CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction. Journal of Stroke and Cerebrovascular Diseases 2013 22 6 709 712 10.1016/j.jstrokecerebrovasdis.2011.10.014 2-s2.0-84881179224
19. Chiang T. L., Taiwan's 1995 health care reform. Health Policy 1997 39 3 225 239 10.1016/S0168-8510(96)00877-9 2-s2.0-0031106732 (Pubitemid 27112426)
20. Tung S.-C., Wang P.-W., Liu R.-T., Clinical characteristics of endogenous cushings syndrome at a medical center in Southern Taiwan. International Journal of Endocrinology 2013 2013 7 685375 10.1155/2013/685375
21. Yaneva M., Kalinov K., Zacharieva S., Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center. European Journal of Endocrinology 2013 169 5 621 627 10.1530/EJE-13-0320
22. Ntali G., Asimakopoulou A., Siamatras T., Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up. European Journal of Endocrinology 2013 169 5 715 723 10.1530/EJE-13-0569
23. Graversen D., Vestergaard P., Stochholm K., Gravholt C. H., Jørgensen J. O. L., Mortality in Cushing's syndrome: a systematic review and meta-analysis. European Journal of Internal Medicine 2012 23 3 278 282 10.1016/j.ejim.2011.10.013 2-s2.0-84858748113
24. Bolland M. J., Holdaway I. M., Berkeley J. E., Lim S., Dransfield W. J., Conaglen J. V., Croxson M. S., Gamble G. D., Hunt P. J., Toomath R. J., Mortality and morbidity in Cushing's syndrome in New Zealand. Clinical Endocrinology 2011 75 4 436 442 10.1111/j.1365-2265.2011.04124.x 2-s2.0-80052526859